In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inverness carries on along acquisition trail

This article was originally published in Clinica

Executive Summary

Inverness Medical Innovations has entered an acquisition agreement with protein-based diagnostics specialist Matritech that will see it clinch its sixth purchase of the year. The Matritech buy, expected to close in the fourth quarter of 2007, will cost Inverness $36m in common stock, possibly highlighting that such prolific purchases have taken their toll on the company's financial reserves.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049567

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel